London-based Perceptic closed a $12 million seed round led by Accel to expand its end-to-end AI platform for pharmaceutical development. The startup was founded by three former Palantir executives who built Palantir's Life Sciences practice.
Perceptic positions itself as a comprehensive AI solution for drug development, with backing from top pharmaceutical companies already using the platform. The funding comes as the biotech sector increasingly adopts machine learning to accelerate research and reduce development timelines.
The startup's founding team brings significant enterprise software experience from Palantir, where they developed tools for intelligence and data analysis. This expertise translates directly to pharma's complex data challenges around molecular analysis, clinical trials, and drug candidate identification.
Ackel's investment signals confidence in AI-driven drug development as a category. The $12 million seed round will likely fund platform expansion and talent recruitment. Perceptic joins a growing cohort of AI-first biotech platforms targeting the $2 trillion pharmaceutical industry.
The company operates in a competitive space alongside initiatives from established pharma giants and well-funded startups, though its enterprise pedigree differentiates its approach to regulatory-grade AI systems.
Indian AI coding startup Emergent reached a $1.5 billion valuation in its latest funding round, raising $130 million in Series C and joining the unicorn club after a five-fold valuation jump in six months.
Rime, an AI platform processing over 100 million calls monthly, secured $24 million in Series A funding to expand its customer service solutions for enterprises.
A former SpaceX engineer has secured $65 million in funding to revolutionize wire harness manufacturing for aerospace and defense. The startup aims to replace decades-old production methods still used in rockets, missiles, and satellites.
Israeli identity management startup Oak has emerged from stealth with $60 million in seed funding. The company, cofounded by veteran entrepreneur Shai Morag, addresses identity management challenges created by the proliferation of AI agents.